TL;DR
This study investigates the factors driving hospitalization costs for diabetic patients in Traditional Chinese Medicine (TCM) hospitals in China. It reveals that hospital level, length of stay, and the presence of complications are the primary cost drivers, with higher-level hospitals incurring significantly greater expenses. The findings underscore the need for optimized TCM hospital management and policy interventions to mitigate the economic burden of diabetes.
What Problem Does This Paper Address?
Diabetes mellitus is a growing global health crisis, placing a substantial economic strain on healthcare systems. While much research focuses on Western medicine approaches, the role and cost-effectiveness of Traditional Chinese Medicine (TCM) in managing chronic diseases like diabetes remain less explored, particularly in specific regional contexts. This paper addresses the gap in understanding the specific factors that influence hospitalization costs for diabetic patients within TCM hospitals in Qingyang City, China. By identifying these drivers, the study aims to provide a scientific basis for TCM hospitals to better manage costs and reduce the financial burden on patients and the healthcare system.
Methods
The researchers employed a multi-stage analytical approach. Initially, univariate analysis was used to identify potential factors associated with hospitalization costs and length of stay. Following this, multiple linear regression was applied to model the relationships between various patient and hospital characteristics and these cost outcomes. Finally, a path model was constructed to further dissect the direct and indirect effects of these factors, particularly examining the mediating role of length of stay on hospitalization costs. This comprehensive approach allowed for a nuanced understanding of the complex interplay of variables influencing costs.
Datasets
The study utilized retrospective data from the National Health Big Data platform of the Health Commission of Gansu Province, China. Specifically, it included medical records of diabetic patients (coded as E10-E14 according to ICD-10) admitted to two TCM hospitals in Qingyang City that had implemented diagnosis-related group (DRG) reform. The data spanned from January 2017 to August 2020. After screening for logical errors and incomplete information, a total of 1268 effective cases were included in the analysis.
Key Insights and Ideas
- Hospital Level is King (for Costs): The most striking finding is the dominant influence of hospital level on hospitalization costs. Tertiary hospitals, representing higher tiers of care, are significantly more expensive than secondary hospitals. This suggests a need to critically evaluate resource allocation and treatment protocols across different hospital tiers within the TCM system.
- Complications Compound Costs: The presence and severity of complications and comorbidities are strong predictors of both longer hospital stays and higher costs. This highlights the importance of proactive diabetes management to prevent or mitigate these complications.
- Length of Stay as a Key Mediator: While direct effects are important, the length of stay acts as a significant mediator, amplifying the impact of factors like hospital level and complications on the final hospitalization cost. This reinforces the idea that efficient patient management and timely discharge are crucial for cost control.
- Type of Diabetes Matters, But Differently: Interestingly, the study found that Type 2 and "other types" of diabetes mellitus were associated with longer stays and higher costs compared to Type 1 diabetes, a finding that contrasts with some European studies. This could be attributed to differences in patient populations, treatment protocols, or the specific types of TCM hospitals studied.
Key Results
- Hospital Level: Tertiary hospitals had significantly higher hospitalization costs and longer lengths of stay compared to secondary hospitals.
- Complications and Comorbidities: The more severe the complications and comorbidities, the longer the length of stay and the higher the hospitalization cost.
- Length of Stay: A longer length of stay was directly correlated with increased hospitalization costs.
- Type of Diabetes: Patients with Type 2 diabetes mellitus and "other types" of diabetes mellitus experienced longer lengths of stay and higher hospitalization costs compared to those with Type 1 diabetes mellitus.
- DRG Reform: The implementation of DRG reform showed a trend towards reduced length of stay and hospitalization costs, indicating its potential effectiveness in cost containment.
Limitations and Future Work
The authors acknowledge several limitations:
- Limited Sample Size and Scope: The study was confined to two TCM hospitals in Qingyang City, Gansu Province. This small sample size and regional focus may limit the generalizability of the findings to other regions or healthcare systems in China.
- Regional Economic Disparities: The uneven distribution of TCM resources and varying economic development levels across China mean that Qingyang City's TCM hospitals may not fully represent the national landscape of cost and treatment.
For future work, the authors suggest:
- Multi-province Sampling: Conducting similar studies across multiple provinces would provide a more comprehensive and representative understanding of hospitalization costs for diabetic patients in TCM hospitals.
- Optimizing TCM Treatment: Further research into optimizing TCM treatment protocols and the hierarchical medical treatment system is recommended to effectively utilize TCM's advantages in managing chronic diseases and alleviate economic pressures.
Summary updated